Mucinous appendiceal neoplasms: Preoperative MR staging and classification compared with surgical and histopathologic findings

American Journal of Roentgenology

Volumn 190, Issue 3, 2008, Pages 656-665

  Low, Russell N ^a   Barone, Robert M ^a   Gurney, Jonathan M ^a   Muller, Wayne D ^a  

^a SHARP MEMORIAL HOSPITAL   (United States)

Author keywords

Disseminated peritoneal adenomucinosis; MRI; Mucinous adenocarcinoma; Peritoneal mucinous carcinomatosis; Pseudomyxoma peritonei

Indexed keywords

GADOLINIUM;

ADULT; AGED; APPENDIX TUMOR; ARTICLE; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MALE; MESENTERY TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERITONEUM TUMOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; APPENDICEAL NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES;

EID: 39749158996     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2018     Document Type: Article

References (34)

1. Cerame MA. A 25-year review of adenocarcinoma of the appendix: a frequently perforating carcinoma. Dis Colon Rectum 1988; 31:143-150
2. Ronnett BM, Zahn CM, Kurman RJ, Lass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguish ing features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol 1995; 19:1390-1408
3. Misdraji JA, Yantiss R, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003; 27:1089-1103
4. Swartz MR. Mucoceles and epithelial tumors of the appendix: a new look at nomenclature and prognostic factors. Adv Anat Pathol 1996; 3:353-361
5. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996; 30:233-280
6. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85:1332-1339
7. Galani E, Marx GM, Steer CB, Culora G, Harper PG. Pseudomyxoma peritonei: the "controversial" disease. Int J Gynecol Cancer 2003; 4:413-418
8. Esqviel J, Sugarbaker PH. Clinical presentation of pseudomyxoma peritonei syndrome. Br J Surg 2000; 87:1414-1418
9. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42
10. Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727-731
11. Sugarbaker PH, Sweatman TW, Graves T, Cunliffe W, Israel NI. Early postoperative intraperitoneal Adriamycin: pharmacologic studies and a preliminary clinical report. Reg Cancer Treatment 1991; 4:127-131
12. Katz MH, Barone RM. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 2003; 12:673-688
13. De Simone M, Barone R, Vaira M, et al. Semi-closed hyperthermic- antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinomatosis. J Surg Oncol 2003; 82:138-140
14. Glehen O, Kwiatkowski F, Sugargaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22:3284-3292
15. Scuderi S, Costamagna D, Vaira M, Barone R, De Simone M. Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy [in Italian]. Tumori 2003; 89[suppl 4]:43-45
16. Walensky RP, Venbrux AC, Prescott CA, Osterman FA Jr. Pseudomyxoma peritonei. AJR 1996; 167:471-474
17. Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR 1994; 163:1131-1140
18. Semelka RC, Lawrence PH, Shoenut JP, Heywood M, Kroeker MA, Lotocki R. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre- and postcontrast, fat-suppressed MR imaging, with histologic correlation. J Magn Reson Imaging 1993; 3:99-106
19. Low RN, Barone RM, Lacey C, et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997; 204:513-520
20. Low RN, Carter WD, Saleh F, Sigeti JS. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 1995; 195:391-400
21. Low RN, Saleh F, Song SYT, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination - a longitudinal study. Radiology 1999; 211:519-525
22. Low RN, Duggan B, Barone RM, Saleh F, Song SY. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 2005; 235:918-926
23. Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR. Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. RadioGraphics 1992; 12:1051-1068
24. Bechtold RE, Chen MYM, Loggie BW, Jackson SL, Geisinger K. CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 2001; 26:406-410
25. Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 1989; 9:115-118
26. Hussain SM, Outwater EK, Siegelman ES. MR imaging features of pelvic mucinous carcinomas. Eur Radiol 2000; 10:885-891
27. Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology 1999; 210:625-632
28. Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 1995; 181:530-538 [Erratum in: J Am Coll Surg 1996; 182:80]
29. Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success of second-look operation. Mod Pathol 2001; 14:164-171
30. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH; Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92:85-91
31. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004; 240:278-285
32. Mukherjee A, Moran BJ. Pseudomyxoma peritonei: symptoms, signs and clinical differential diagnosis. J Gynecol Oncol 2003; 8:199-203
33. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg 1997; 30:233-280
34. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002; 223:495-499